A New Way to Control Pain

The Food and Drug Administration (FDA) recently gave approval to GlaxoSmithKline (GSK) for their new OTC pain product, Advil Dual Action with Acetaminophen. This pain medication contains 250mg of ibuprofen and 500 mg of acetaminophen. It is the first OTC combination of ibuprofen and acetaminophen for pain control. This combination fights pain in two different ways. The first way is with ibuprofen, a non-steroidal anti-inflammatory drug (NSAID), that targets pain at the source by blocking the production of prostaglandins which cause swelling and pain signaling in the body. The second way is with acetaminophen, which blocks pain signals from being sent to the brain. This medication gained approval based on several studies to demonstrate efficacy and safety for pain relief. The data from these studies support that the fixed dose combination of ibuprofen and acetaminophen had better outcomes for pain relief than using ibuprofen or acetaminophen individually.  Advil Dual Action will be available later in 2020.

 

Posted April 2020

Leave a Reply